🔎 Trials Near Me

Akèy › Sipwa › Illinois › Chicago

Etid klinik pou Sipwa nan Chicago, IL

28 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2
  • Charter Research LLC - Chicago, Chicago
  • Flourish Research - Chicago, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Great Lakes Clinical Trials, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Chicago Research Center, Inc, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Ap rekriteFaz 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3
  • Rush University Medical Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ap rekriteFaz 3
  • Ann and Robert Lurie Children's Hospital of Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3
  • Rush University Medical Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Eagle Clinical Research, Chicago
  • University of Chicago, Chicago
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Flourish Research - Great Lakes Clinical Trials, Chicago
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

BRIDGE & Friends Trial

Ap rekriteVolontè an sante akeyi
  • University of Illinois Chicago, Chicago
Laj 50 a 79 · Tout sèks · Mizajou Sep 1, 2026 · NCT07798557

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Ap rekriteVolontè an sante akeyi
  • Illinois Institute of Technology, Chicago
Laj 21 a 74 · Tout sèks · Mizajou Aug 27, 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Chicago
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Ap rekrite
  • Jesse Brown VA Medical Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Ap rekriteFaz 2
  • Mile Square Health Center Chicago, Chicago
  • Mile Square Health Center - Auburn Gresham, Chicago
  • Mile Square Health Center - Englewood, Chicago
  • ak 1 plis
Tout laj · Tout sèks · Mizajou Jul 10, 2026 · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

Ap rekrite
  • University of Illinois at Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Laj 18 a 40 · Fanm · Mizajou Jul 9, 2026 · NCT05234125

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Ap rekriteEtid obsèvasyon
  • Northwestern Memorial Hospital, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Mar 17, 2026 · NCT07207148

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Ap rekriteFaz 3
  • University of Chicago, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Nov 14, 2025 · NCT06499857

Etid Sipwa nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.